Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Successful initial administration and full enrollment in first-in-human LIBERATE-1™ study of NPM-115
(exenatide implant) in obese and overweight subjects with top-line data expected in mid-2025

Read more at globenewswire.com